Chronic automated red cell exchange therapy for sickle cell disease
Transfusion · 2024-08 · 64 (8) · 1509-1519
DOI: 10.1111/trf.17924 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, online erschienen am 14.07.2024. Verfasst von Abdulhafiz Zakieh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Hematology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Erythrocyte Transfusion. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Background
The data to support chronic automated red cell exchange (RCE) in sickle cell disease (SCD) outside of stroke prevention, is limited, especially in adults. Study Design and Methods A retrospective analysis was conducted of patients with SCD who were referred for chronic RCE at our institution over a 10‐year period. Data that were evaluated included patient demographics, referral indications, and procedural details (e.g., vascular access, adverse events, etc.). In a subanalysis, the number of annual acute care encounters during 3 years of chronic RCE was compared with that in the year preceding the first RCE.
Results
A total of 164 patients were referred for chronic RCE: median age was 28 years (interquartile range [IQR] = 22–36) at referral and 60% were female. Seventy (42.6%) were naïve to chronic transfusion (simple or RCE) prior to referral. The leading indications for referral were refractory pain (73/164, 44.5%) and iron overload (57/164, 34.7%). A total of 5090 procedures occurred during the study period (median = 19, IQR = 5–45). Of the 138 patients who had central vascular access, 8 (6%) and 16 (12%) had ≥1 central‐line‐related thrombosis and/or infection, respectively. Of those who were not RBC alloimmunized at initiation of RCE, 12/105 (11.4%) developed new antibodies during chronic RCE. In those 30 patients who were adherent to therapy for 3 years, there was no significant difference in acute care encounters following initiation of RCE.
Conclusion
Prospective clinical trials are needed to determine which patients are most likely to benefit from chronic RCE and refine selection accordingly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Pediatric Hematology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
- Department of Pathology, Division of Transfusion Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Hematology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Vitalant, Scottsdale, Arizona, USA.
ORCID-Profile: Elizabeth P Crowe, Aaron A R Tobian, Evan M Bloch
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Zakieh, A., Mercure-Corriveau, N., Lanzkron, S., Feng, X., Vozniak, S., Crowe, E. P., Rai, H., Lawrence, C., Bekkouri, D., Goel, R., Tobian, A. A. R., & Bloch, E. M. (2024). Chronic automated red cell exchange therapy for sickle cell disease. Transfusion, 64(8), 1509-1519. https://doi.org/10.1111/trf.17924
Vancouver
Zakieh A, Mercure-Corriveau N, Lanzkron S, Feng X, Vozniak S, Crowe EP, et al. Chronic automated red cell exchange therapy for sickle cell disease. Transfusion. 2024;64(8):1509-1519. doi:10.1111/trf.17924
BibTeX
@article{Zakieh2024,
author = {Zakieh, Abdulhafiz and Mercure-Corriveau, Nicolas and Lanzkron, Sophie and Feng, Xinyi and Vozniak, Sonja and Crowe, Elizabeth P and Rai, Herleen and Lawrence, Courtney and Bekkouri, Denise and Goel, Ruchika and Tobian, Aaron A R and Bloch, Evan M},
title = {Chronic automated red cell exchange therapy for sickle cell disease},
journal = {Transfusion},
year = {2024},
volume = {64},
number = {8},
pages = {1509--1519},
doi = {10.1111/trf.17924}
}
EUVIMED